Inventiva IVEVF
NASDAQ IVEVF
$3.59 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Inventiva (IVEVF) Selling, General & Administrative (2019 - 2021)

Analysis

Inventiva (IVEVF) Selling, General & Administrative (2019 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Johnson & Johnson 645.47 Bn 624.71 Bn 17.26 Bn 6.43 Bn
2 AbbVie 439.99 Bn 433.42 Bn 12.70 Bn 3.63 Bn
3 Merck 365.45 Bn 358.31 Bn 12.21 Bn 2.90 Bn
4 Novartis Ag 266.57 Bn 258.88 Bn 11.24 Bn -3.24 Bn
5 Pfizer 159.03 Bn 147.33 Bn 10.94 Bn 3.41 Bn
6 Sanofi 52.43 Bn 45.05 Bn 10.79 Bn -2.87 Bn
7 Revolution Medicines 44.23 Bn 44.23 Bn - 110.21 Mn
8 Incyte 25.32 Bn 20.79 Bn 1.57 Bn 351.74 Mn
9 United Therapeutics 21.44 Bn 18.77 Bn 683.80 Mn 206.70 Mn
10 Inventiva 693.72 Mn 693.72 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 -3.66 Mn
Mar 31, 2021 -3.30 Mn
Dec 31, 2020 -10.13 Mn
Jun 30, 2020 -2.02 Mn
Mar 31, 2020 -1.71 Mn
Dec 31, 2019 -6.74 Mn